Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
2002 · PubMed · 158 citations
E
Ellen S. Vitetta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
307
Papers
14.6K
Citations
65
h-index
203
i10-index
Ellen S. Vitetta is an academic researcher from Southwestern Medical Center. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Toxin Mechanisms and Immunotoxins & Transgenic Plants and Applications. The author has an h-index of 65, co-authored 261 publications.
Papers by this author
worksCellular Interactions in the Humoral Immune Response
1989 · Advances in immunology · 118 citations
https://doi.org/10.1016/s0065-2776(08)60692-6
Multiepitope HER2 Targeting Enhances Photoimmunotherapy of HER2-Overexpressing Cancer Cells with Pyropheophorbide-a Immunoconjugates
2005 · Cancer Research · 83 citations
https://doi.org/10.1158/0008-5472.can-05-0426
Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy.
1994 · PubMed · 69 citations
The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice
2000 · Breast Cancer Research and Treatment · 51 citations
https://doi.org/10.1023/a:1006494001861
Cancer Dormancy: Lessons from a B Cell Lymphoma and Adenocarcinoma of the Prostate
2007 · Advances in cancer research · 22 citations
https://doi.org/10.1016/s0065-230x(06)97008-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat